Cullinan Management (CGEM) IPO Doubles on Open, Trims Gains

January 8, 2021 12:45 PM EST

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Today's IPO for Cullinan Management, Inc. (NASDAQ: CGEM) opened earlier at $42 after pricing its upsized initial public offering of 11,900,000 shares of common stock at a price to the public of $21.00 per share. Shares have since moved down to $34.50.

All shares are being offered by Cullinan Management. In addition, the underwriters have a 30-day option to purchase up to an additional 1,785,000 shares of common stock at the initial public offering price less underwriting discounts and commissions.

Morgan Stanley & Co. LLC, SVB Leerink LLC, and Evercore Group LLC are acting as joint book-running managers for the offering. H.C. Wainwright & Co., LLC is acting as lead manager for the offering.

Cullinan Management is a biopharmaceutical company focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. The Company’s strategy is to build a pipeline of therapeutic candidates that are uncorrelated across multiple dimensions, with a focus on assets that it believes have novel technology, employ differentiated mechanisms, are in a more advanced stage of development than competing candidates, or have a combination of these attributes.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot IPOs, IPOs

Related Entities

Morgan Stanley, IPO, H.C. Wainwright